Jacobio Pharmaceuticals Co., Ltd.

This early-stage trial tested an oral drug called JAB-3312 in 40 adults with advanced solid tumors (like lung, colon, or breast cancer) that had stopped responding to standard treatments. The main goals were to find a safe dose and check for side effects. Researchers also looked …

This study tested a new drug called JAB-21822, alone or with another drug (cetuximab), in 29 adults with advanced solid tumors that have a specific genetic change (KRAS G12C). The goal was to check safety and how well the drug works. Participants had already tried at least one st…

This early-phase study tested a new drug called JAB-8263 in 41 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find a safe dose and check for side effects. The study is now complete.

This study tested a new drug called JAB-BX102, given alone or with another drug (pembrolizumab), in 21 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose, while also looking for early s…